Operating Lease, Right-of-Use Asset of IMMUCELL CORP /DE/ from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IMMUCELL CORP /DE/ quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,419,527, a 3.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IMMUCELL CORP /DE/ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,419,527 -$173,191 -3.8% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $4,542,863 +$40,268 +0.89% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $4,527,379 -$18,682 -0.41% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $4,560,679 -$10,470 -0.23% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $4,592,718 +$376,475 +8.9% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $4,502,595 +$217,627 +5.1% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $4,546,061 +$2,367,927 +109% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $4,571,149 +$2,376,479 +108% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $4,216,243 +$2,000,007 +90% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $4,284,968 +$3,233,841 +308% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $2,178,134 +$1,100,083 +102% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,194,670 +$1,085,537 +98% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $2,216,236 +$1,079,296 +95% 30 Sep 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 $1,051,127 -$113,620 -9.8% 30 Jun 2022 10-Q/A 21 Nov 2022 2022 Q2
Q1 2022 $1,078,051 -$114,503 -9.6% 31 Mar 2022 10-Q/A 21 Nov 2022 2022 Q1
Q4 2021 $1,109,133 -$111,228 -9.1% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $1,136,940 -$109,926 -8.8% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $1,164,747 -$114,198 -8.9% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,192,554 -$112,896 -8.6% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $1,220,361 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $1,246,866 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $1,278,945 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $1,305,450 31 Mar 2020 10-Q 13 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.